Frontlight ResearchEarly access
Myeloproliferative neoplasms trials, also abroad
239 open Myeloproliferative neoplasms trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.
The same trial often runs in several countries
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF) has 2 sites in Netherlands and runs in 24 countries. If a site near you is full, another one may still take people.
See A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF) in all 24 countries